Home

Weniger Ökologie Taiko Bauch ppar agonist diabetes Menge Gelehrter Gestreift

Re-highlighting the action of PPARγ in... | F1000Research
Re-highlighting the action of PPARγ in... | F1000Research

Frontiers | PPAR-γ Modulators as Current and Potential Cancer Treatments
Frontiers | PPAR-γ Modulators as Current and Potential Cancer Treatments

Peroxisome proliferator-activated receptor γ in diabetes and metabolism -  ScienceDirect
Peroxisome proliferator-activated receptor γ in diabetes and metabolism - ScienceDirect

Positive Reinforcing Mechanisms between GPR120 and PPARγ Modulate Insulin  Sensitivity - ScienceDirect
Positive Reinforcing Mechanisms between GPR120 and PPARγ Modulate Insulin Sensitivity - ScienceDirect

The Many Faces of PPARγ: Cell
The Many Faces of PPARγ: Cell

Frontiers | PPAR-γ Agonists As Antineoplastic Agents in Cancers with  Dysregulated IGF Axis
Frontiers | PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis

PDB-101: Global Health: Diabetes Mellitus: Drugs: Thiazolidinedione: PPAR-γ
PDB-101: Global Health: Diabetes Mellitus: Drugs: Thiazolidinedione: PPAR-γ

Frontiers | The Role of Peroxisome Proliferator-Activated Receptor Gamma  and Atherosclerosis: Post-translational Modification and Selective  Modulators
Frontiers | The Role of Peroxisome Proliferator-Activated Receptor Gamma and Atherosclerosis: Post-translational Modification and Selective Modulators

PPAR Inhibition | PPAR Agonist Review
PPAR Inhibition | PPAR Agonist Review

effects of dual PPAR alpha and gamma agonists in ADD | Download Table
effects of dual PPAR alpha and gamma agonists in ADD | Download Table

Frontiers | Peroxisome Proliferator-Activated Receptors: Experimental  Targeting for the Treatment of Inflammatory Bowel Diseases
Frontiers | Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases

Adipocyte NCoR Knockout Decreases PPARγ Phosphorylation and Enhances PPARγ  Activity and Insulin Sensitivity: Cell
Adipocyte NCoR Knockout Decreases PPARγ Phosphorylation and Enhances PPARγ Activity and Insulin Sensitivity: Cell

Molecules | Free Full-Text | Pharmacological (or Synthetic) and Nutritional  Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19  Disease
Molecules | Free Full-Text | Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease

Obesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in  Type 2 Diabetes | Arteriosclerosis, Thrombosis, and Vascular Biology
Obesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in Type 2 Diabetes | Arteriosclerosis, Thrombosis, and Vascular Biology

PPARgamma agonists in the treatment of type II diabetes: is increased  fatness commensurate with long-term efficacy? | International Journal of  Obesity
PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? | International Journal of Obesity

Diabetes & Metabolism Journal
Diabetes & Metabolism Journal

PDB-101: Global Health: Diabetes Mellitus: Drugs: Thiazolidinedione: PPAR-γ
PDB-101: Global Health: Diabetes Mellitus: Drugs: Thiazolidinedione: PPAR-γ

PPAR agonist is not a SARM – Evolutionary.org
PPAR agonist is not a SARM – Evolutionary.org

The Role of PPAR Agonists in Diabetes Mellitus
The Role of PPAR Agonists in Diabetes Mellitus

Gescheiterte PPAR-Agonisten: Glitazare und GLP-1 – neuer Ansatz bei Diabetes ?
Gescheiterte PPAR-Agonisten: Glitazare und GLP-1 – neuer Ansatz bei Diabetes ?

Therapeutic potential of PPARγ natural agonists in liver diseases - Wu -  2020 - Journal of Cellular and Molecular Medicine - Wiley Online Library
Therapeutic potential of PPARγ natural agonists in liver diseases - Wu - 2020 - Journal of Cellular and Molecular Medicine - Wiley Online Library

Impact of peroxisome proliferator-activated receptor-α on diabetic  cardiomyopathy | Cardiovascular Diabetology | Full Text
Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy | Cardiovascular Diabetology | Full Text

Dual PPARα + PPARγ agonists (glitazars) | Download Scientific Diagram
Dual PPARα + PPARγ agonists (glitazars) | Download Scientific Diagram

IJMS | Free Full-Text | PPAR Agonists and Metabolic Syndrome: An  Established Role?
IJMS | Free Full-Text | PPAR Agonists and Metabolic Syndrome: An Established Role?